CLYM

NASDAQStock

Climb Bio, Inc.

$6.99-0.27 (-3.72%)

52-Week Range

$1.13

$7.39

Key Stats

Market Cap

476.6M

P/E Ratio

—

Dividend Yield

—

Beta

-0.23

Volume

383.3K

Avg Volume

707.6K

Performance

+28.04%

+90.55%

+261.19%

YTD

+93.60%

+418.57%

+42.35%

Price Chart

ETF Exposure

CLYM is held by 11 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.05%	82,370	$604K	$1.27B	0.60%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	8,176	$59K	$10.37B	0.12%
VXF	Vanguard Extended Market ETF	0.00%	277,618	$1.2M	$84.10B	0.05%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	4,981	$36K	$40.55B	0.17%
DFAS	Dimensional - US Small Cap ETF	0.00%	111	$805	$12.65B	0.26%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	42	$254	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,501	$9K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	7	$43	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	854,986	$3.8M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	4,497	$27K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	387	$2K	$1.29B	0.17%

About CLYM ETF Exposure

Climb Bio, Inc. (CLYM) is held by 11 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 476.6M, CLYM is a widely held institutional stock. The stock currently trades at $6.99. Investors can gain exposure to CLYM through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CLYM, sorted by portfolio weight.